Company News

Share this article:

GlaxoSmithKline announced that it will form a joint venture with China-based Jiangsu Walvax Biotech Company to develop pediatric vaccines for measles, mumps and rubella in China. GSK is investing $29.7 million in the deal initially, and will invest an additional $10.7 million in 2015, according to a company statement.

EMD Serono Canada tapped Ariad Healthcare to market its probiotic multivitamin Multibionta – the number one selling multivitamin in France and the UK – in Canada. Other partners on the assignment include Rao Barrett & Welsh, Environics and M2 Universal.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.